Regression of prostate cancer xenografts by a lentiviral vector specifically expressing diphtheria toxin A
- 22 September 2003
- journal article
- Published by Springer Nature in Cancer Gene Therapy
- Vol. 10 (10) , 764-770
- https://doi.org/10.1038/sj.cgt.7700629
Abstract
We have constructed a prostate-specific lentiviral vector based on the promoter of the prostate-specific antigen (PSA). The PSA promoter-based lentiviral vector has been used to deliver the diphtheria toxin A (DTA) gene into prostate cancer cells, and has shown promising tissue-specific eradication of prostate cancer cells in cell culture. To evaluate the efficacy of eradicating human prostate cancer cells in vivo, we used human LNCaP prostate xenografts in nude mice as an animal model and found that with a single injection of the DTA lentiviral vector into LNCaP prostate tumors, approximately 75% of the tumors (from three experiments; conducted 9/11, 11/15 and 3/4) in the animals were completely eradicated. The DTA vector has also shown the ability to cause tumor regression in recurrent prostate tumors. Intravenous injection of the DTA lentiviral vector into nude mice elicited no pathogenic effects, suggesting that this prostate tissue-specific vector is safe for eradicating prostate cancer cells in vivo.Keywords
This publication has 26 references indexed in Scilit:
- Superior Tissue-Specific Expression from Tyrosinase and Prostate-Specific Antigen Promoters/Enhancers in Helper-Dependent Compared with First-Generation Adenoviral VectorsHuman Gene Therapy, 2002
- Ex Vivo and In Vitro Studies of Transgene Expression in Rat Astrocytes Transduced with Lentiviral VectorsExperimental Neurology, 2002
- Prostate-specific targeting using PSA promoter-based lentiviral vectorsCancer Gene Therapy, 2001
- Targeting and eradicating cancer cells by a prostate-specific vector carrying the diphtheria toxin A geneCancer Gene Therapy, 2000
- Efficient transfer, integration, and sustained long-term expression of the transgene in adult rat brains injected with a lentiviral vector.Proceedings of the National Academy of Sciences, 1996
- Cell type specific and inducible promoters for vectors in gene therapy as an approach for cell targetingJournal of Molecular Medicine, 1996
- In Vivo Gene Delivery and Stable Transduction of Nondividing Cells by a Lentiviral VectorScience, 1996
- Tissue-Specific Gene Expression from Mo-MLV Retroviral Vectors with Hybrid LTRs Containing the Murine Tyrosinase Enhancer/PromoterVirology, 1995
- Prostate Tissue Specificity of the Prostate-Specific Antigen Promoter Isolated from a Patient with Prostate CancerHuman Gene Therapy, 1995
- A Retroviral Vector Containing a Muscle-Specific Enhancer Drives Gene Expression Only in Differentiated Muscle FibersHuman Gene Therapy, 1995